학술논문
Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia
Document Type
Article
Author
Source
In Biology of Blood and Marrow Transplantation January 2016 22(1):80-85
Subject
Language
ISSN
1083-8791